Who Owns Marvell Technology Stock (MRVL) Ahead of Q3 Earnings?

Marvell Technology (MRVL) is set to report Q3 earnings on December 1. Shares have fallen 42% in a month but are up 63% year-to-date. ETFs own 32.91% of MRVL, with BlackRock and iShares as top holders. Analysts expect EPS of $1.10 and revenue of $3.15B. Bank of America downgraded MRVL to Hold, citing acquisition concerns, while Oppenheimer maintained a Buy rating.

Original reporting
Published Nov 20, 2026, 2:48 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 20, 2026, 3:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MRVL
Bearish
high confidence
Mentioned
$MRVL
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$MRVLBearishMed
01

Why it matters

Analyst downgrade and target cut introduce fresh negative sentiment ahead of earnings, increasing short‑term downside risk.

02

Market read

The downgrade adds new, material information that could influence MRVL's price action before its earnings release.

03

What to watch

Strong demand for MRVL's custom AI chips may offset dilution concerns if the integration proceeds smoothly.

Relevance 7/10Novelty 6/10Timing: pre‑market before Q3 earnings on Dec 1

Background

Marvell Technology (MRVL) is set to report Q3 FY27 results on Dec 1. The stock has fallen 42% over the past month amid concerns over its $100 B Lumentum acquisition and macro pressures.

Company-level read

Ticker impact

$MRVLBearishHigh confidence
Context

Bank of America downgraded MRVL to Hold and cut its price target to $225, citing regulatory overhang and dilution from the Lumentum acquisition ahead of the Q3 earnings release.

Expected impact

likely downside as investors price in regulatory risk and share‑count dilution.

Evidence & confidence

The downgrade is a fresh, material analyst action with specific concerns; no comparable downgrade has been reported previously.

Market effects

Highlights regulatory and integration risks for semiconductor M&A, potentially affecting peers considering similar deals.

U.S. semiconductor sector may see modest pullback as investors reassess deal‑related overhang.

Limited to tech investors; no broad macro impact.

Counterpoint

Oppenheimer maintains a Buy rating with a $425 target, arguing the combined AI connectivity platform could unlock significant upside.

Key entities

  • Bank of America

    Downgraded MRVL to Hold and cut price target to $225.

  • Oppenheimer

    Reiterated Buy rating with a $425 price target.

Related articles

$AVGOMed

Broadcom Plunges 11% as Google Reportedly Shifts TPU Orders to MediaTek, Overshadowing Goldman’s $460 Target; Marvell Sinks 10%

Broadcom (AVGO) fell 11% after reports that Google (GOOGL) may shift some TPU orders to MediaTek, raising concerns about customer concentration. Analyst Ming-Chi Kuo estimated a 20% reduction in Google's 2027 TPU orders for Broadcom. Goldman Sachs lowered its price target to $460 but maintained a Buy rating. Marvell (MRVL) also dropped 10%, while NVIDIA (NVDA) fell 7%. Broadcom's AI revenue grew 221% YoY in Q3 FY2026, and it expects $21.7B in AI revenue for Q4 FY2026.

$MRVLHighAI 9/10

Marvell and Lumentum deal: good, real, and ugly scenarios

Marvell Technology (MRVL) and Lumentum Holdings (LITE) are discussing a potential merger. MRVL trades at $126.38, down 8.73%, with a market cap of $111.59B. LITE trades at $482.95, down 9.75%, with a market cap of $44.10B. The deal aims to combine MRVL's platform ambition with LITE's optical capacity, with projected annual synergies of over $1B. The transaction is all-stock, with LITE shareholders receiving 4.5 MRVL shares per share.

$MRVLMed

Why is Marvell Technology stock sliding today?

Marvell Technology (MRVL) fell 8.3% to $126.98, extending a decline tied to its proposed all-stock acquisition of Lumentum Holdings. The deal values Lumentum at about $115B and would leave Marvell shareholders with ~67%. Stifel cut its MRVL target to $280 from $370; Oppenheimer kept a $425 Buy.

$CRDOMed

Credo Sinks 8% in a Week, Marvell 8%, as Bessent Calls for a Nvidia “Dramatic Shakeup.” Time to Buy?

Credo Technology (CRDO) fell 8% in a week amid AI chip sector turbulence, including an 8% drop for Marvell (MRVL). The decline followed Nvidia (NVDA) CEO's resignation and calls for a 'dramatic shakeup.' Credo settled a patent dispute with Marvell, crucial for its growth. TD Cowen cut its price target to $175 but maintained a Buy rating. Credo trades at 17x forward earnings, well below its 3-year average of 61x, ahead of its Dec. 1 earnings report.